CHAI and partners, including UNAIDS, the Bill & Melinda Gates Foundation, Unitaid, the United Kingdom’s Department for International Development, PEPFAR, USAID, and the Global Fund to Fight AIDS, Tuberculosis and Malaria, announce a groundbreaking agreement with Aurobindo and Viatris to accelerate the availability of the first affordable, generic, single-pill HIV treatment containing DTG, a best-in-class HIV medication, to public sector purchasers in low- and middle-income countries at around US$75 per person, per year.